166 related articles for article (PubMed ID: 38809874)
41. Emergency department burden of hyperemesis gravidarum in the United States from 2006 to 2014.
Geeganage G; Iturrino J; Shainker SA; Ballou S; Rangan V; Nee J
AJOG Glob Rep; 2023 Feb; 3(1):100166. PubMed ID: 36876158
[TBL] [Abstract][Full Text] [Related]
42. Cannabinoid hyperemesis syndrome as the underlying cause of intractable nausea and vomiting.
Price SL; Fisher C; Kumar R; Hilgerson A
J Am Osteopath Assoc; 2011 Mar; 111(3):166-9. PubMed ID: 21464265
[TBL] [Abstract][Full Text] [Related]
43. Cannabis use in the United States and its impact on gastrointestinal health.
Alshaarawy O; Balasubramanian G; Venkatesan T
Nutr Clin Pract; 2024 Apr; 39(2):281-292. PubMed ID: 38142306
[TBL] [Abstract][Full Text] [Related]
44. Effects of the 2009 Medical Cannabinoid Legalization Policy on Hospital Use for Cannabinoid Dependency and Persistent Vomiting.
Al-Shammari M; Herrera K; Liu X; Gisi B; Yamashita T; Han KT; Azab M; Mashiana H; Maklad M; Farooqui MT; Makar R; Yoo JW
Clin Gastroenterol Hepatol; 2017 Dec; 15(12):1876-1881. PubMed ID: 28711691
[TBL] [Abstract][Full Text] [Related]
45. Emergency Department and Radiological Cost of Delayed Diagnosis of Cannabinoid Hyperemesis.
Zimmer DI; McCauley R; Konanki V; Dynako J; Zackariya N; Shariff F; Miller J; Binz S; Walsh M
J Addict; 2019; 2019():1307345. PubMed ID: 30723570
[No Abstract] [Full Text] [Related]
46. Emergency Department Treatment of Cannabinoid Hyperemesis Syndrome: A Review.
Khattar N; Routsolias JC
Am J Ther; 2018; 25(3):e357-e361. PubMed ID: 28953512
[TBL] [Abstract][Full Text] [Related]
47. Cannabinoid hyperemesis syndrome: Review of the literature and of cases reported to the French addictovigilance network.
Schreck B; Wagneur N; Caillet P; Gérardin M; Cholet J; Spadari M; Authier N; Tournebize J; Gaillard M; Serre A; Carton L; Pain S; Jolliet P; Victorri-Vigneau C
Drug Alcohol Depend; 2018 Jan; 182():27-32. PubMed ID: 29132050
[TBL] [Abstract][Full Text] [Related]
48. Cannabinoid Hyperemesis Encounters After Medical Legalization in Oklahoma.
Riha R; Winchell R; Safo D; Gentges J
Cureus; 2023 Oct; 15(10):e46465. PubMed ID: 37927644
[TBL] [Abstract][Full Text] [Related]
49. Association between non-medical cannabis legalization and emergency department visits for cannabis-induced psychosis.
Myran DT; Pugliese M; Roberts RL; Solmi M; Perlman CM; Fiedorowicz J; Tanuseputro P; Anderson KK
Mol Psychiatry; 2023 Oct; 28(10):4251-4260. PubMed ID: 37500826
[TBL] [Abstract][Full Text] [Related]
50. Cannabinoid Poisoning-Related Emergency Department Visits and Inpatient Hospitalizations in Kentucky, 2017 to 2019.
Britch SC; Walsh SL; Vickers-Smith R; Babalonis S; Slavova S
Subst Use Misuse; 2023; 58(1):66-76. PubMed ID: 36453437
[No Abstract] [Full Text] [Related]
51. Cannabinoid hyperemesis syndrome.
Elnagar A; Kgomo M; Mokone M; Yousif B
BMJ Case Rep; 2024 Apr; 17(4):. PubMed ID: 38688569
[TBL] [Abstract][Full Text] [Related]
52. Cannabis-related emergency department visits by youths and their outcomes in Ontario: a trend analysis.
Bechard M; Cloutier P; Lima I; Salamatmanesh M; Zemek R; Bhatt M; Suntharalingam S; Kurdyak P; Baker M; Gardner W
CMAJ Open; 2022; 10(1):E100-E108. PubMed ID: 35135825
[TBL] [Abstract][Full Text] [Related]
53. Natural language processing improves estimates of the epidemiology of cannabinoid hyperemesis syndrome.
Hewitt M; Ma P; Coyle E; Leidlein S; Jennings K; Wanis N; Miller J
Am J Emerg Med; 2023 Aug; 70():198-199. PubMed ID: 37349236
[No Abstract] [Full Text] [Related]
54. Cannabinoid Hyperemesis Syndrome: An Unexpected Problem in an Unusual Setting-A Case Report.
Stuart R; Richards JR
Mil Med; 2020 Sep; 185(9-10):e1894-e1896. PubMed ID: 32472123
[TBL] [Abstract][Full Text] [Related]
55. Cannabinoid hyperemesis syndrome masquerading as an eating disorder.
Brewerton TD; Anderson O
Int J Eat Disord; 2016 Aug; 49(8):826-9. PubMed ID: 26842268
[TBL] [Abstract][Full Text] [Related]
56. Cannabinoid hyperemesis syndrome: potential mechanisms for the benefit of capsaicin and hot water hydrotherapy in treatment.
Richards JR; Lapoint JM; Burillo-Putze G
Clin Toxicol (Phila); 2018 Jan; 56(1):15-24. PubMed ID: 28730896
[TBL] [Abstract][Full Text] [Related]
57. Cannabinoid hyperemesis syndrome: a cause of refractory nausea and vomiting in pregnancy.
Alaniz VI; Liss J; Metz TD; Stickrath E
Obstet Gynecol; 2015 Jun; 125(6):1484-1486. PubMed ID: 25774930
[TBL] [Abstract][Full Text] [Related]
58. [Cannabinoid hyperemesis syndrome causing prolonged nausea and vomiting in patients with cannabis abuse].
Naver AV; Theede K
Ugeskr Laeger; 2015 Apr; 177(18):. PubMed ID: 25922240
[TBL] [Abstract][Full Text] [Related]
59. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids.
Hopkins CY; Gilchrist BL
J Emerg Med; 2013 Oct; 45(4):544-6. PubMed ID: 23890687
[TBL] [Abstract][Full Text] [Related]
60. Efficacy of topical capsaicin for cannabinoid hyperemesis syndrome in a pediatric and adult emergency department.
Kum V; Bell A; Fang W; VanWert E
Am J Emerg Med; 2021 Nov; 49():343-351. PubMed ID: 34242945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
